Why Thais Choose Stem Cell Services in Korea with EHL BIO's Global Standards

Quick answer

Thais choose stem cell services in Korea due to strict safety standards under the Advanced Regenerative Bio Act, regulated by the Ministry of Health and MFDS, combined with EHL BIO's proprietary culture technology yielding 1,000x more cells and a dedicated Thai coordination team for seamless care.

Key takeaways

GMP standards and Korea's first CPC certification ensuring international trust.
Proprietary cell culture technology yielding 1,000 times higher quality cells than competitors.
Safety and quality control under the Korean Advanced Regenerative Bio Act.
A 6-step service process specifically designed for the convenience of Thai patients.

Safety Standards and Korean Regenerative Medicine Legislation

A primary reason Thais trust Korean recovery processes is the strict enforcement of the 'Advanced Regenerative Bio Act,' regulated by the Ministry of Health and Welfare and the Korean Food and Drug Administration (MFDS). EHL BIO is the first institution in Korea to be approved as a 'Human Cell Management Business,' covering sample collection, safety testing, and cell processing at the highest standards. This ensures patients that every cell is managed within a transparent system as evaluated by the EHL team.

Furthermore, the EHL Cell Center is located in Apgujeong, Seoul, a premier medical hub, equipped with Class 100 cleanroom facilities and CPC (Cell Processing Center) certification. South Korea’s robust biological infrastructure makes cell therapy an increasingly popular choice for Thai patients seeking a better quality of life through reliable medical innovation.

EHL BIO’s Specialized Cell Culture Technology

EHL BIO stands out with its technology for isolating and culturing Adipose-derived Stem Cells. Our specialized expertise enables a cell yield 1,000 times higher than conventional methods while maintaining excellent cell viability under GMP standards, supporting up to 6,000 lots per year. This mass-production capability ensures that patients receive high-quality cells in sufficient quantities for their personalized recovery and quality of life goals as evaluated by our medical team.

Utilizing autologous cells (self-derived) is key to minimizing immune rejection and enhancing safety for recovering from degenerative conditions such as osteoarthritis, chronic kidney disease, or atopic dermatitis. Currently, our products like ADSTEM and KDSTEM are in various stages of medical development and clinical trials, aiming to become new standards for managing challenging conditions in the future.

We are dedicated to advancing regenerative medicine and cell therapy innovations to grant health and longevity to humanity.

Integrated Care and Thai Coordination Team

EHL Thailand understands the concerns regarding communication and international travel. We have established a dedicated Thai coordination team to support patients through every step, from initial consultation and medical record evaluation by the Korean research team to appointment booking and travel planning. The entire 6-step process is designed to be seamless, starting with a web consultation and providing on-site support at the EHL Cell Center in Korea.

Moreover, after receiving services and returning to Thailand, EHL BIO maintains a follow-up system to continuously monitor the patient’s quality of life and recovery. With a network of over 100 partner hospitals in Korea, alongside collaborations with prestigious university hospitals such as Chonnam National University and Yonsei University, our strong medical network ensures the best possible care for all Thai patients.

Aging Well Innovation for Longevity

The ultimate goal of EHL BIO is achieving 'Aging Well'—maintaining health as one ages to enhance longevity. We are dedicated to developing therapies covering both stem cells and immune cells, such as NK cells and T cells, to strengthen the body’s defenses against chronic inflammation and cellular degeneration. Our cell freezing technology at -196°C preserves cell potency for future use.

Beyond clinical care, we apply biotechnology to aesthetics and skincare, using MFDS-certified Exosomes and Conditioned Media to develop products like Cellon Skin and klosome. These have become highly popular among health-conscious and beauty-oriented Thais. Choosing services in Korea is thus a long-term investment in health, utilizing today’s most advanced medical innovations.

Frequently asked questions

What are the recovery and quality of life goals when choosing EHL BIO in Korea for cell culture?

EHL BIO utilizes proprietary technology that yields 1,000 times more cells than standard methods, operating under strict GMP standards and Korea's rigorous Advanced Regenerative Bio Act, for effective health recovery goals as evaluated by the EHL team.

How do Thai patients communicate with the EHL BIO center?

EHL Thailand provides a dedicated Thai coordination team to assist with travel planning, medical evaluation by doctors, and follow-up care after returning to Thailand.

How is recovery safety regulated in Korea?

It is regulated by the Ministry of Health and MFDS of South Korea. EHL BIO was the first in Korea to be legally certified as a Human Cell Management Business.